Case Studies
ESMO 2023 Coverage
Prof. Harbeck & Prof. Barrios
ESMO 2023 Coverage – Part 1
Watch time: 25 min
Latest results on CDK4/6 inhibitors in hormone receptor positive, HER2 negative early breast cancer data.
ESMO 2023 Coverage Part 2
Watch time: 6 min
Impact of adherence long term oral medications in the adjuvant setting and the use of technology to improve the QoL of a patient.
Highlights from the ESMO 2023 meeting
Clinical Advances in the Treatment of Early and Advanced High-risk Breast Cancer